Insider Transactions in Q2 2023 at Pliant Therapeutics, Inc. (PLRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,750
+14.25%
|
$61,500
$2.08 P/Share
|
|
Jun 09
2023
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,800
+3.62%
|
$11,600
$2.08 P/Share
|
|
Apr 03
2023
|
Mike Ouimette General Counsel & Corp. Sec'y |
SELL
Open market or private sale
|
Direct |
2,877
-2.69%
|
$77,679
$27.1 P/Share
|